4D Pharma PLC (DDDD)

London
16.66
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    15.28 - 16.72

DDDD Overview

Prev. Close
15.86
Day's Range
15.28-16.72
Revenue
198K
Open
15.84
52 wk Range
13.6-77
EPS
-0.34
Volume
0
Market Cap
30.04M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
912,373
P/E Ratio
-1.09
Beta
3.15
1-Year Change
-71.81%
Shares Outstanding
180,337,577
Next Earnings Date
25 Apr 2023
What is your sentiment on 4D Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

4D Pharma PLC News

4D Pharma PLC Company Profile

4D Pharma PLC Company Profile

Employees
106

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn’s disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

Read More

Analyst Price Target

Average75.00 (+350.18% Upside)
High75
Low75
Price16.66
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • News rich q4 share price starting to recover!!
    3
    • whats going on today why price going up today?
      0
      • Bullish 100%
        2
        • Seems the bubble well and truly burst lol, expected a jump and got a puncture
          0
          • So much for the jump in share price after being listed on the NASDAQ
            2
            • Any news on the NASDAQ?
              2
              • Any more news on the stock appearing on the NASDAQ?
                0
                • Is this stock worth holding or sell now?
                  0
                  • Hold- new NASDAQ listing should help boost the shareprice. looking for 2.50 minimum for these shares
                    0
                  • Calum Burnsthank you, really appreciated
                    0
                • Supposedly hitting the NASDAQ sometime is Q1
                  0
                  • Is it worth holding on to or sell on?
                    0
                • Looking forward to see 4D get a boost when it appears on NASDAQ
                  0
                  • Any ideas when this is supposed to happen?
                    0
                  • When roughly?
                    0